<SEC-DOCUMENT>0001159036-25-000047.txt : 20251105
<SEC-HEADER>0001159036-25-000047.hdr.sgml : 20251105
<ACCEPTANCE-DATETIME>20251105165947
ACCESSION NUMBER:		0001159036-25-000047
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20251105
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251105
DATE AS OF CHANGE:		20251105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HALOZYME THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001159036
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				880488686
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32335
		FILM NUMBER:		251454919

	BUSINESS ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 794-8889

	MAIL ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HALOZYME THERAPEUTICS INC
		DATE OF NAME CHANGE:	20040312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL YACHT SERVICES INC
		DATE OF NAME CHANGE:	20010912
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>halo-20251105.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e88b901f-a656-46ed-87b8-e20ae8b500a6,g:a16acab7-19a0-4699-aad1-87a668625893,d:0c7df3b29dd94d18a0e0b898a026eec2-->
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>halo-20251105</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-21">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001159036</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="halo-20251105.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-05</xbrli:startDate><xbrli:endDate>2025-11-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0c7df3b29dd94d18a0e0b898a026eec2_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">____________________________________________</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________________________</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of The Securities Exchange Act of 1934</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">                                    </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.597%"><tr><td style="width:1.0%"/><td style="width:55.037%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Date of Report (Date of Earliest Event Reported):</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 5, 2025</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:5pt;padding-left:90pt;padding-right:90pt;text-align:center"><img src="halo-20251105_g1.jpg" alt="Halo Logo updated.jpg" style="height:67px;margin-bottom:5pt;vertical-align:text-bottom;width:211px" id="i-1"/></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">HALOZYME THERAPEUTICS, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-4">001-32335</ix:nonNumeric> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">88-0488686</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">12390 El Camino Real</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-8">92130</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">794-8889</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:3pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.971%"><tr><td style="width:1.0%"/><td style="width:33.241%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.320%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">HALO</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:right"><span style="color:#231f20;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#231f20;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric> </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01 Entry into a Material Definitive Agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 5, 2025, Halozyme Therapeutics, Inc. (the &#8220;Company&#8221;), Halozyme, Inc. (&#8220;Halozyme&#8221;) and certain other subsidiaries of the Company entered into an Amendment No. 3 (the &#8220;Amendment&#8221;) to the Company&#8217;s Credit Agreement, dated as of May 24, 2022 (as previously amended, restated, amended and restated, supplemented or otherwise modified from time to time, the &#8220;Credit Agreement&#8221;; capitalized terms used but not defined herein shall have the meanings assigned therefor in the Credit Agreement), by and among, inter alios, the Company, Halozyme, the other guarantors party thereto, the lenders party thereto, Bank of America, N.A., as the administrative agent and swing line lender. Pursuant to the Amendment, the Company (a) extended the maturity date of the existing revolving credit facility under the Credit Agreement immediately prior to the effectiveness of the Amendment (the &#8220;Existing Revolving Credit Facility&#8221; and, as amended and upsized as set forth in clause (b) below, the &#8220;Amended Revolving Credit Facility&#8221;), and (b) incurred additional revolving credit commitments such that the aggregate amount of commitments under the Amended Revolving Credit Facility equal $750,000,000 in total.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">After giving effect to the Amendment, the Amended Revolving Credit Facility will mature on the earlier of (a) November 5, 2030 and (b) the Springing Revolver Maturity Date, unless the Amended Revolving Credit Facility is extended prior to such date in accordance with the Credit Agreement.  Borrowings under the Amended Revolving Credit Facility bear interest at a rate equal to an applicable margin plus: (a) the applicable Term SOFR (as defined in the Credit Agreement) rate, or (b) a base rate determined by reference to the highest of (1) the federal funds effective rate plus 0.50%, (2) the Bank of America prime rate, (3) the Term SOFR rate for an interest period of one month plus 1.00%, and (4) 1.00%. The applicable margin for the Amended Revolving Credit Facility ranges, based on the Company&#8217;s consolidated total net leverage ratio, from 0.25% to 1.25% in the case of base rate loans and from 1.25% to 2.25% in the case of Term SOFR rate loans.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains an expansion feature, which allows the Company, subject to certain conditions, to establish a term loan facility and/or to increase the aggregate principal amount of the Amended Revolving Credit Facility, provided that certain customary conditions are satisfied, including that the Company&#8217;s consolidated secured net leverage ratio shall not exceed 3.50 to 1.00 on a pro forma basis.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Amended Revolving Credit Facility include certain affirmative and negative covenants as set forth in the Credit Agreement, that, among other things, may restrict the Company&#8217;s ability to: create liens on assets; incur additional indebtedness; make investments; make acquisitions and other fundamental changes; and sell and dispose of property or assets. The Credit Agreement also includes financial covenants requiring the Company to maintain, measured as of the end of each fiscal quarter, a maximum consolidated net leverage ratio of 4.50 to 1.00, and a minimum consolidated interest coverage ratio of 3.00 to 1.00. If the Company consummates a material acquisition the consolidated net leverage ratio covenant will be increased by 0.50 to 1.00 (to a level not to exceed 5.00 to 1.00) for a period of three fiscal quarters following such material acquisition. The Credit Agreement also contains customary affirmative covenants, representations and warranties and events of default.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Except as amended by the Amendment, the terms of the Credit Agreement remain in full force and effect. As of November 5, 2025, after giving effect to the Amendment and the transactions contemplated therein, the Company had $0 of outstanding borrowings under the Credit Agreement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Amendment is not complete and is qualified in its entirety by reference to the Amendment which the Company intends to file as an exhibit to its Annual Report on Form 10-K for the year ended 2025.</span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information included in Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 2.03 by reference.</span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 Other Events.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 5, 2025, the Company issued a press release announcing that it proposes to offer, subject to market conditions and other factors, $650.0 million aggregate principal amount of convertible senior notes due 2031 (the &#8220;2031 Notes&#8221;) and $650.0 million aggregate principal amount of convertible senior notes due 2032 (the &#8220;2032 Notes&#8221;). The Company also expects to grant a 13-day option to the initial purchasers to purchase up to an additional $100.0 million aggregate principal amount of the 2031 Notes and up to an additional $100.0 million aggregate principal amount of the 2032 Notes. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 8.01 by reference.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d) </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span></div><div style="margin-bottom:8pt;margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Document Description</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991halo-launchpressrelea.htm">99.1</a></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Press release, dated November 5, 2025.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">*Certain schedules omitted pursuant to Item 601(a)(5) of Regulation S-K. Halozyme agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.132%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HALOZYME THERAPEUTICS, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 5, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Nicole LaBrosse</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991halo-launchpressrelea.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i56143f6f5ecd4415b5c4c467ac98796b_1"></div><div style="min-height:123.84pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><img alt="image_1.jpg" src="image_1.jpg" style="height:90px;margin-bottom:5pt;vertical-align:text-bottom;width:234px"></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">FOR IMMEDIATE RELEASE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Halozyme Therapeutics, Inc. Announces Proposed Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">SAN DIEGO, CA (November 5, 2025)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> &#8212; Halozyme Therapeutics, Inc. (NASDAQ&#58; HALO) (&#8220;Halozyme&#8221; or the &#8220;Company&#8221;), today announced that it intends to offer, subject to market conditions and other factors, $650 million aggregate principal amount of convertible senior notes due 2031 (the &#8220;2031 Notes&#8221;) and $650 million aggregate principal amount of convertible senior notes due 2032 (the &#8220;2032 Notes&#8221; and, together with the 2031 Notes, the &#8220;Convertible Notes&#8221;). The Company also expects to grant a 13-day option to the initial purchasers to purchase up to an additional $100 million aggregate principal amount of the 2031 Notes and up to an additional $100 million aggregate principal amount of the 2032 Notes. The Convertible Notes are to be offered and sold only to persons reasonably believed to be &#8220;qualified institutional buyers&#8221; pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Convertible Notes will be senior, unsecured obligations of the Company and will accrue interest payable semi-annually in arrears. The 2031 Notes will mature on February 15, 2031, and the 2032 Notes will mature on November 15, 2032, in each case, unless earlier redeemed, repurchased or converted in accordance with their respective terms prior to such dates. Prior to the close of business on the business day immediately preceding August 15, 2030, the 2031 Notes will be convertible only upon the satisfaction of certain conditions and during certain periods, and on and after August 15, 2030, at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date of the 2031 Notes, the 2031 Notes will be convertible regardless of these conditions. Prior to the close of business on the business day immediately preceding May 15, 2032, the 2032 Notes will be convertible only upon the satisfaction of certain conditions and during certain periods, and on and after May 15, 2032, at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date of the 2032 Notes, the 2032 Notes will be convertible regardless of these conditions. The Company will settle conversions in cash and, if applicable, shares of the Company&#8217;s common stock, at the Company&#8217;s election. The initial conversion rate, interest rate and other terms of each series of the Convertible Notes will be determined at the time of pricing in negotiations with the initial purchasers of the Convertible Notes.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">In connection with the pricing of the Convertible Notes, the Company intends to enter into privately negotiated capped call transactions relating to each series of Convertible Notes with one or more financial institutions, which may include one or more of the initial purchasers and&#47;or their respective affiliates. The capped call transactions relating to the 2031 Notes will initially cover, subject to customary adjustments, the number of shares of our common that will initially underlie the 2031 Notes, and the capped call transactions relating to the 2032 Notes will initially cover, subject to customary adjustments, the number of shares of our common stock that will initially underlie the 2032 Notes. If the initial purchasers exercise their option to purchase </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:123.84pt;width:100%"><div><img alt="image_1.jpg" src="image_1.jpg" style="height:90px;margin-bottom:5pt;vertical-align:text-bottom;width:234px"></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">additional notes, the Company may enter into additional capped call transactions with the option counterparties. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Company expects to use a portion of net proceeds of the offering to fund the cost of entering into the capped call transactions. The Company also expects to use a portion of the net proceeds of the offering to enter into privately negotiated agreements with certain holders of its outstanding 0.25% convertible senior notes due 2027 (the &#8220;2027 Notes&#8221;) and 1.00% convertible senior notes due 2028 (the &#8220;2028 Notes&#8221; and, together with the 2027 Notes, the &#8220;Existing Convertible Notes&#8221;) to repurchase their Existing Convertible Notes for cash through privately negotiated transactions entered into concurrently with or shortly after the pricing of the proposed offering (the &#8220;Note Repurchases&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Company intends to use the remainder of the net proceeds from the offering for general corporate purposes, including working capital, capital expenditures, potential acquisitions and strategic transactions, and, potentially, future note repurchases including repurchases of the Existing Convertible Notes from time to time following the offering or for the repayment of the Notes at maturity. If the initial purchasers exercise their option to purchase additional notes, the Company intends to use a portion of the net proceeds from the sale of additional notes to fund the cost of entering into additional capped call transactions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Note Repurchases could increase (or reduce the size of any decrease in) the market price of the Company&#8217;s common stock or the Convertible Notes. We also expect that some existing noteholders may purchase or sell shares of the Company&#8217;s common stock in the market to hedge their exposure in connection with these transactions. The Note Repurchases and any associated hedging by holders could affect the market price of the Company&#8217;s common stock prior to, concurrently with or shortly after the pricing of the Convertible Notes and could also result in a higher effective conversion price for the Convertible Notes.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The capped call transactions relating to each series of Convertible Notes are generally expected to reduce potential dilution to the Company&#8217;s common stock upon conversion of the Convertible Notes and&#47;or offset the amount of any potential cash payments the Company may be required to make in excess of the principal amount of converted Convertible Notes of such series, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, which initially corresponds to the conversion price of the Convertible Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of our common stock, as measured under the terms of the capped call transactions, exceeds the cap price of the capped call transactions, there would nevertheless be dilution and&#47;or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the capped call transactions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:123.84pt;width:100%"><div><img alt="image_1.jpg" src="image_1.jpg" style="height:90px;margin-bottom:5pt;vertical-align:text-bottom;width:234px"></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Company has been advised that, in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to enter into various derivative transactions with respect to our common stock and&#47;or purchase shares of our common stock concurrently with or shortly after the pricing of the Convertible Notes. This activity could increase (or reduce the size of any decrease in) the market price of our common stock or the Convertible Notes at that time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">In addition, the Company has been advised that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and&#47;or purchasing or selling our common stock or selling our common stock or other securities of ours in secondary market transactions following the pricing of the Convertible Notes and from time to time prior to the maturity of the Convertible Notes (and (x) are likely to do so during any observation period related to a conversion of the Convertible Notes, following any redemption of the Convertible Notes by us, or following any repurchase of the Convertible Notes by us in connection with any fundamental change and (y) are likely to do so following any repurchase of Convertible Notes by us other than in connection with any such redemption or any fundamental change if we elect to unwind a corresponding portion of the capped call transactions in connection with such repurchase). This activity could also cause or avoid an increase or decrease in the market price of our common stock or the Convertible Notes, which could affect a holder&#8217;s ability to convert its Convertible Notes and, to the extent the activity occurs during any observation period related to a conversion of a series of Convertible Notes, it could affect the number of shares of our common stock and value of the consideration that a holder will receive upon conversion of its Convertible Notes.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">This press release is neither an offer to sell nor a solicitation of an offer to buy the Convertible Notes or the shares of the Company&#8217;s common stock issuable upon conversion of the Convertible Notes, if any, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. Any offer of these securities will be made only by means of a private offering memorandum.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The offer and sale of the Convertible Notes and the shares of the Company&#8217;s common stock issuable upon conversion of the Convertible Notes, if any, have not been registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Forward-looking Statements </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, regarding the planned offering. Words such as &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:123.84pt;width:100%"><div><img alt="image_1.jpg" src="image_1.jpg" style="height:90px;margin-bottom:5pt;vertical-align:text-bottom;width:234px"></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;forecasts,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;will,&#8221; &#8220;believes&#8221; and words and terms of similar substance used in connection with any discussion identify forward-looking statements. These forward-looking statements are based on management&#8217;s current expectations and beliefs about future events and are inherently susceptible to uncertainty and changes in circumstances. Except as required by law, the Company is under no obligation to, and expressly disclaims any obligation to, update or alter any forward-looking statements whether as a result of such changes, new information, subsequent events or otherwise. With respect to the planned offering, such uncertainties and circumstances include whether the Company will offer the Convertible Notes or consummate the offering&#894; and the anticipated terms of the Convertible Notes and the use of the net proceeds from the offering. Various factors could also adversely affect the Company&#8217;s operations, business or financial results in the future and cause the Company&#8217;s actual results to differ materially from those contained in the forward-looking statements, including those factors discussed in detail in the &#8220;Risk Factors&#8221; sections contained in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company&#8217;s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025, which are filed with the Securities and Exchange Commission.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">About Halozyme</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZE&#174; drug delivery technology with the proprietary enzyme rHuPH20, Halozyme's commercially-validated solution is used to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE&#174; technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and Acumen Pharmaceuticals.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide commercial or functional advantages such as improved convenience, reliability and tolerability, and enhanced patient comfort and adherence. The Company has two commercial proprietary products, Hylenex&#174; and XYOSTED&#174;, partnered commercial products and ongoing product development programs with Teva Pharmaceuticals and McDermott Laboratories Limited, an affiliate of Viatris Inc.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Halozyme is headquartered in San Diego, CA and has offices in Ewing, NJ and Minnetonka, MN. Minnetonka is also the site of its operations facility.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:123.84pt;width:100%"><div><img alt="image_1.jpg" src="image_1.jpg" style="height:90px;margin-bottom:5pt;vertical-align:text-bottom;width:234px"></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Contacts</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Tram Bui</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">VP, Investor Relations and Corporate Communications</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">609-333-7668</font></div><div style="margin-bottom:12pt"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">tbui&#64;halozyme.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Sydney Charlton<br>Teneo</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">917-972-8407</font></div><div style="margin-bottom:12pt"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">sydney.charlton&#64;teneo.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>halo-20251105.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e88b901f-a656-46ed-87b8-e20ae8b500a6,g:a16acab7-19a0-4699-aad1-87a668625893-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:halo="http://www.halozyme.com/20251105" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.halozyme.com/20251105">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20251105_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20251105_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.halozyme.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>halo-20251105_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e88b901f-a656-46ed-87b8-e20ae8b500a6,g:a16acab7-19a0-4699-aad1-87a668625893-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_04717388-b511-4230-b88c-8dfc1bc4c4de_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_49c925f1-b6c3-4869-ba84-46b8b51c207a_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7483fd6b-f948-4d7f-813d-ef5aced20f15_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_5b7239d2-8646-4b35-bd46-a1b9c1aca09d_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_78e30678-e39b-4de6-b0e0-0f270b9799b0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_0b83dcda-ca72-4fcc-8c16-e23fc2c7b555_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4f54c66b-beaa-4333-b1d5-b18ccbb34817_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b026fdaa-9bc0-42ed-99eb-563704393858_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_6e07f9bc-4ec9-49f1-b250-acef120d479f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_84d717b6-2b51-4262-bc8f-e19c5f94b044_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9a5a31a6-6343-4321-a439-790222d55b00_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1e0a3b11-3aee-4f15-bd15-f1a5538f9366_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_be96df49-4f1b-4460-8baa-5a9f042cb4fe_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_954a701b-6bc1-4308-a5c7-0ac2dec24038_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_978dbc9e-b6f0-4f5d-b052-8e8c7d135693_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cb253607-50f4-43c1-9abb-25962df43292_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_06974f57-90a8-4e4b-bbc7-1fede4ece269_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2532a2a7-4a8a-4481-9df2-db6f1333cbce_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_39928952-b056-4267-b28c-f79373444da1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d2e1a191-e82d-49bb-831b-f846dbd432e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6d606540-09d3-41c3-ade2-b3024ba7b06a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e0f6bd05-a264-405b-8664-8e127e166c09_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8bb95afa-d044-427b-99bc-a8c1007278cf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>halo-20251105_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e88b901f-a656-46ed-87b8-e20ae8b500a6,g:a16acab7-19a0-4699-aad1-87a668625893-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.halozyme.com/role/CoverPage" xlink:type="simple" xlink:href="halo-20251105.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f5e28038-cfe0-4b95-912f-dca34867858b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_DocumentType_f5e28038-cfe0-4b95-912f-dca34867858b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e23d4b48-4d0e-48e2-bc80-4294b1d523c8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_DocumentPeriodEndDate_e23d4b48-4d0e-48e2-bc80-4294b1d523c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7ecd6215-dd2e-43a8-9990-bdd96be03c86" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityRegistrantName_7ecd6215-dd2e-43a8-9990-bdd96be03c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7057240c-e0a3-4c77-b203-545da893e43b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityFileNumber_7057240c-e0a3-4c77-b203-545da893e43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4abd5214-8517-4ba2-a26e-40ef58b6d80b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4abd5214-8517-4ba2-a26e-40ef58b6d80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_719d9e21-5fef-43bc-8b38-fba173fcdbcc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityTaxIdentificationNumber_719d9e21-5fef-43bc-8b38-fba173fcdbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e9f74e66-cfec-4ec4-8818-057dde09ad0b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityAddressAddressLine1_e9f74e66-cfec-4ec4-8818-057dde09ad0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_af28069c-1ea9-4405-9177-8ce572bef37d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityAddressCityOrTown_af28069c-1ea9-4405-9177-8ce572bef37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5b100546-6cf1-4a60-8a60-9de54b12afc6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityAddressStateOrProvince_5b100546-6cf1-4a60-8a60-9de54b12afc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_aaa9e97a-3009-47d4-ab3e-ad120da5ee8f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityAddressPostalZipCode_aaa9e97a-3009-47d4-ab3e-ad120da5ee8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bf9a4af1-6379-4adc-98f5-d1af3c0cfe3b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_CityAreaCode_bf9a4af1-6379-4adc-98f5-d1af3c0cfe3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f3198a92-3a6d-46b2-ac51-d5c3c5f7b82f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_LocalPhoneNumber_f3198a92-3a6d-46b2-ac51-d5c3c5f7b82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_13076594-5bfc-426d-9095-ee97cae75b1f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_WrittenCommunications_13076594-5bfc-426d-9095-ee97cae75b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_ee73c241-94ff-4482-b3ba-fa7d569e5f26" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_SolicitingMaterial_ee73c241-94ff-4482-b3ba-fa7d569e5f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_96762db2-f639-4cc4-bb6c-3412cb2a57ee" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_PreCommencementTenderOffer_96762db2-f639-4cc4-bb6c-3412cb2a57ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_119b7bb2-6183-42c3-a3de-bdc2c85967a0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_119b7bb2-6183-42c3-a3de-bdc2c85967a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b4238696-69dd-437e-a0f4-fc45f018751d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_Security12bTitle_b4238696-69dd-437e-a0f4-fc45f018751d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d7720e58-d82d-4c82-b4b6-8443c96ed8b1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_TradingSymbol_d7720e58-d82d-4c82-b4b6-8443c96ed8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_92114e9e-d34e-471f-acd8-8f7d649a88dd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_SecurityExchangeName_92114e9e-d34e-471f-acd8-8f7d649a88dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c5ec54a1-d664-4139-b85b-b37b446bc013" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityEmergingGrowthCompany_c5ec54a1-d664-4139-b85b-b37b446bc013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b756c007-b3eb-4777-b633-7aac913626e8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_AmendmentFlag_b756c007-b3eb-4777-b633-7aac913626e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5ea40d67-87a7-4dd6-bf14-147db6337ed4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ce938b6-3249-42de-9fd3-e613fdab5f20" xlink:to="loc_dei_EntityCentralIndexKey_5ea40d67-87a7-4dd6-bf14-147db6337ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>halo-20251105_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20251105_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #,S8
M )*2  (    #,S8  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" "F 9D# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\[5]-D\;4Y2[O\O^'/D<^G>K"'9?G_PP %F 4$DG  [U]4Z;:_8=)M+3_GA
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MHD&EZU#=6B"..\5F9%& '4C./KD'ZYK*OAO9+G@SEQF 6'C[6D]CNO!GB?\
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M/J,UYM\3/$3W-Q'X<TTEW9E^T!.K,?NI_(_E78>*-=A\+>'6G7!EVB*VC/\
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MZ6V.3'("?Q7_ !KU.O+?C!_Q]Z5_N2?S6A :GQ$O'C^'MD@;FY>%7]P$+?S
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MEL<6#HO%8AU)[;O_ "-BBBBO8/J0HHHH **** "BBB@ HHHH **** "BBB@
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M@ #H*X8Q]I6<WLM$<<(>VQ+JO:.B]>HZBBBNH]$**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDL@BA>1@2$4L0/844
M4">Q@^#[$1Z6^J2X:ZU1OM,K#L&Y51[ '^==#116=/2",L.DJ4;=@HHHK0V"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !5 -T# 2(  A$! Q$!_\0
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MD^5GM)UE"_\ ?-:;.$3<U #J*Y^'QSX<O+LVD&OZ7-=YV_9TO(V?_OG=704
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MV3['?:C$CPP72*B[&W_=^Y_X^E4!HW?P[_9[N-)^PKJ'A^W^7:MW#JZ"5?\
M:W[ZPOA]\?M/^&LVL>%?$VM1^*-/TZ5/[)UBW9;@S0.N[8S ]4RH]L[?X*]D
MO?A1\,["QDO;GPSX=MK%4W-<R6T2Q[?]ZN"\!6G@#XDW.N2Z+\,=(N-'L;K[
M/!J4MO'''=G!W% R=C@_1EI ?0 J&65((7D<[45=S-Z5*&^Z?6O./C]XE_X1
M/X-^+=01@DHT^6*-O1Y/W:?^/.*=*$JM2-./VC"M5C0IRJR^R?%7[.WAE_C/
M^T;<:W<H7T^UO)=:N"W=_,WPK_WTR_\  4:O9OVQ_&'F:EI7A:%QB!?MEPO^
MTWRQK^6__OH5T7[&/@6+P%\(6U_442"YUMOM[RM_!;(#Y>?PW/\ \#KR'PQH
MEQ^T!\:;RXGW_P!G3W+7%T[<;+=?E1/]_;M6M>,\:L5B7AL/M\$/D?EM&A4P
MV54L/#^+B9<Q['^R9\,#HFD2^*[^WV7>I*!:J_\ RS@Y^;_@7'_ 53U-?2 [
M55MK6&R@C@@C6*)%VJJCY5'I4X?AF]*\[#T8X>E&E _2L%A(8*A&A#H)'$L.
M[8JKN;<VVIJ**ZCO,/Q/X8TWQAH5WHVJP&YT^[7;+#N9-WS;OO+5O1](MM!T
MBRTVQC$-G90I!!'G.U%7:OZ"M&B@#G?&7@S2/'NARZ1K=F+RPE97:+S&3YE/
MR_,M:&H:'8ZMI,NF7UK'=Z?+'Y4MO.NY'6M*B@#QA_V4?AZ\S,EC>PVSMO:S
MBOI?)8_3-=C#\)_"MG?>'[JVT>.WDT-)$T_R7=%@#_?^4':V[_:KMJ* .;M/
M!&C67C"_\306FS6KZ%;>>Y\UOG1=NT;?N_PK6)X\^"OA#XCSQW&M:0KWZKM6
M]MW:*4#_ 'E^]_P*N_HH \M\(_LZ>!?!VK+JEKI<U_J41WQ7.H3O.T7^YN^6
MK/B_X#>"O'NMR:OKVDR7^H.BIYS7DZA%7^%55PJUZ310!X__ ,,H?"W_ *%Q
MO_!C=?\ QVM;XW^-U^&/PNU"YL\)?R1K8:;"I^;S7^5=O^ZN6_X#7I59FHZ/
M8:H8'O;*VO/(?S8OM$*OY3_WEW?=:@#E?@OX#7X;?#C2-%952]$?GWC#^*=_
MF?\ ^)_X#6QJO@S1M:\3:3X@NK3SM4TG>EI<&1U\K?\ *WRYVFNEHH *YSP=
MX)T;P'I<MAHEI]CM)9VN&C\QG^=OO'YJZ.B@#G/%O@?1O'$6GQZS9_;5L;I+
MV >8R[94^ZWRU/XF\(Z5XST>73-:T^#4;*7[T4R9_P"!+_=:MRB@#Q6+]D[X
M?I+$)+2_N+:)MR6<U]*85/TS7K6CZ+9>']-@T_3+:*PLH%VQV\";50>PK0HH
M KJ5;=[]:\0_:CT^X\8Z%X5\$V999/$FLQPS;.JVT2M+*_\ P'8M>W@+EL5S
M-SX<AO?'.FZ_-*K"PLYK:U@VYV-*RF5\_P"[$B_]]5MA:OL*RJ+>/Y_9/.Q]
M%XFA*A_-_P"D_:_\E//_ -I'Q#!X#^$AT?3XU@^WJNF6\<?\$87D8_W5*_\
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? **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  05,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HALOZYME THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0488686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12390 El Camino Real<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">794-8889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HALO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001159036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="halo-20251105.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="halo-20251105.htm">halo-20251105.htm</File>
    <File>halo-20251105.xsd</File>
    <File>halo-20251105_lab.xml</File>
    <File>halo-20251105_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>halo-20251105_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "halo-20251105.htm": {
   "nsprefix": "halo",
   "nsuri": "http://www.halozyme.com/20251105",
   "dts": {
    "inline": {
     "local": [
      "halo-20251105.htm"
     ]
    },
    "schema": {
     "local": [
      "halo-20251105.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "halo-20251105_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "halo-20251105_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.halozyme.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20251105.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20251105.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001159036-25-000047-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001159036-25-000047-xbrl.zip
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M>F/$D:2"HU=^OA%0H8Y>\<$?LB$DPTP@JS1=SJNQFQF9\;O,N[J66.-@&):
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M^]]C^#SXO/!YW_]FZ'W^K=+_!U!+ P04    " !WAV5;_P\>+A87   @F@
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MT'-LB_VHT7_'\7-$GK'VT.<6&O>VQJ!C.G^%$+.)T$NH@E7E2=/<0AI<<#(
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M^E-#D6HGLMA:7H0/*$N _9TDXQE+>CVWT$-I7G-&-9H U5:P&>8. Y&;M F
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M]\H)9EF1QTE-(1VG]%.*%<U.BHSB, ;,BG$<0_IQ,8$DA1**$YKD$!M8GE.
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M3W*W:5%_U;;_S];1&;8[/AO\ 5!+ P04    " !WAV5;0XQ3O/0@  #@/0
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M+[G4< :W/F5QS-M1B3JQZM_KU]@_K16%/\AD;Q OBU5HAM->U;9L>Q&[>9D
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M/'(_)!HG"9C?OZ8C"-#N[QN\=CO@O- _@ ]0BR, ,\+@O:*W>*Z5-DM,68R
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MLX C(]5N9Q>K/>O<T;HPZC8ON]R]NK;_.5/M1CPB(H:6*BJ5/;P+(0,B4C&
M0F%M%"8P['UBLTW@R&AM)8.MIB-:K34YC-90IVYH.9IT^^)PAQ._KPZW!1SO
MR\,==AI?'^Y:YX[692[**],N'A8RF\]XS+14W !)$VA[5J2!A!$&S# 5:Q1&
ME(=]F6I$/C),&ZU@+=8?HJ;[P_1X>W+#IJ<=)UQ:4_?BI!EI-$!:#=3):%_@
M.\A]6JHLO\GRZI3'12$*<YK=+HO\X3339J8DCD(*8Q#!A-CF8SL0%U("''&*
M[< 78H[=YKI.O7'&O$8*OP15$K9JP2:1H,S$=?;K+F/?4?#%BN,U&0ZJB\>X
MV,OM@.FQ._[(PV0OL[NS9;^7^8^:",O+M)B;&:0\MHTP!AP*!H@A$DAIQTR4
M&&V(4093[CIF;H,?NRN6&D&6! C_0_XSV*J[SYB/Q>@_7_I8=&R2CNZ\ALOG
M-@8-EH_!1A\JG]MH&RAWUOAVSO=:VW_;JH+R2WZ>9S]2F^C,-DPLL(@!$4P
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M5J@'&N_6"BWI-^ZLT/;\/A3J%;5=Y/O)J^TCZ?ING2>O_@]02P,$%     @
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M>^CUUS$]SF'6Y @9IY MG,OA27P?BO?>8G[I,MZ(A%59Q>W5*3?K7<2J;7;
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M_@M02P$"% ,4    " !WAV5; #(GLBT3  "R5   '@              @ $
M    97@Y.3%H86QO+6QA=6YC:'!R97-S<F5L96$N:'1M4$L! A0#%     @
M=X=E6_\/'BX6%P  ()H  !$              ( !:1,  &AA;&\M,C R-3$Q
M,#4N:'1M4$L! A0#%     @ =X=E6_8&&%%C @  !@<  !$
M ( !KBH  &AA;&\M,C R-3$Q,#4N>'-D4$L! A0#%     @ =X=E6T.,4[ST
M(   X#T  !0              ( !0"T  &AA;&\M,C R-3$Q,#5?9S$N:G!G
M4$L! A0#%     @ =X=E6WG738PB"@  ?54  !4              ( !9DX
M &AA;&\M,C R-3$Q,#5?;&%B+GAM;%!+ 0(4 Q0    ( '>'95L&%HY4M 8
M .HP   5              "  ;M8  !H86QO+3(P,C4Q,3 U7W!R92YX;6Q0
52P4&      8 !@"2 0  HE\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>halo-20251105_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="halo-20251105.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2025-11-05</startDate>
            <endDate>2025-11-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001159036</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-11-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">HALOZYME THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="c-1" id="f-4">001-32335</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">88-0488686</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">12390 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-8">92130</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">CA</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode contextRef="c-1" id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">794-8889</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">HALO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
